- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03866226
The Effect of ABPM on Sleep Disturbance (EMBED)
November 5, 2022 updated by: XiaoHong PAN, Second Affiliated Hospital, School of Medicine, Zhejiang University
The Effect of Ambulatory Blood Pressure Monitoring on Sleep Disturbance
Ambulatory blood pressure monitoring (ABPM) is an ideal tool for the diagnosis and evaluation of hypertension.However, ABPM frequently measures the tightening feeling and buzzing sound of the blood pressure cuff during nighttime, which can cause the patient to wake up easily during sleep, which will affect the sleep of the patient.
Moreover, improper awakening of the patient from sleep can significantly increase the patient's blood pressure and affect the accuracy of ABPM monitoring.
The Effect of ABPM on Sleep Disturbance (EMBED) study is designed to examine whether ABPM affects sleep, as well as the relationship and influencing factors of sleep and ABPM results, and screening for people who are susceptible to ABPM testing.
Study Overview
Status
Completed
Conditions
Detailed Description
Participants who accept ABPM in the Second Affiliated Hospital of Zhejiang University School of Medicine, will be recruited for EMBED enrollment.
Participants will be asked to provide basic background information and to fill out the STOP-BANG evaluation form.
Anxiety, depression, insomnia, sleep questionnaire and pain assessment scale for cuff inflation are used to assess characteristics of participants and their sleep quality.
Before ABPM starts, office blood pressure of participants will be measured.
Participants will undergo ABPM under standardized guidance.
At the end of ABPM, participants will be asked to fill in sleep questionnaire and pain assessment scale for cuff inflation again.
EMBED proposes to study whether ABPM affects sleep, as well as the relationship and influencing factors of sleep and ABPM results, and screening for people who are susceptible to ABPM testing.
A better understanding of interaction between ABPM and sleep will help us further evaluate the accuracy of ABPM and more precisely control diurnal hypertension in the future.
Study Type
Observational
Enrollment (Actual)
564
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Zhejiang
-
Hangzhou, Zhejiang, China, 310000
- The Second Affiliated hospital of Zhejiang University School of Medicine
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 80 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
Participants who undergo ABPM in the Second Affiliated Hospital of Zhejiang University School of Medicine
Description
Inclusion Criteria:
- Signed written informed consent
- Age 18-80 years
- Capable of understanding the test and cooperating with the questionnaire.
Exclusion Criteria:
- History of psychosis, including schizophrenia, bipolar disorder, depression, anxiety, obsessive-compulsive disorder, phobia, somatoform disorder, stress-related disorders
- History of insomnia, currently with medication
- History of obstructive sleep apnea (OSA)
- History of other sleep disorders, including narcolepsy/hypersomnias, circadian rhythm sleep disorder, parasomnias, sleep-related dyskinesia
- History of heart failure, that is New York heart association (NYHA) Class Ⅲ-Ⅳ
- History of atrial fibrillation and frequent atrial or ventricular extrasystoles
- Ongoing substance or alcohol abuse
- Currently receiving sedative hypnotic medication within 1 week
- Pregnant women
- Ongoing involvement in night-shift work (22:00-6:00) within 1 week
- Ongoing need of care of families at home that wake during the night within 1 week
- Incomprehensible or unwilling to fill in informed consent or questionnaire
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Ecologic or Community
- Time Perspectives: Cross-Sectional
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Sleep questionnaire score will be used to evaluate the alteration of sleep
Time Frame: about 2 days
|
Sleep questionnaire score
|
about 2 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 10, 2019
Primary Completion (Actual)
August 31, 2022
Study Completion (Actual)
October 30, 2022
Study Registration Dates
First Submitted
March 5, 2019
First Submitted That Met QC Criteria
March 6, 2019
First Posted (Actual)
March 7, 2019
Study Record Updates
Last Update Posted (Actual)
November 8, 2022
Last Update Submitted That Met QC Criteria
November 5, 2022
Last Verified
November 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- I2017001235
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.